☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
WuXi Biologics
WuXi Signed a License Agreement with GSK to Develop Multiple Novel Bi- & Multi-specific T Cell Engagers to Treat Cancer
January 5, 2023
PharmaShots Weekly Snapshots (Mar 15 - 19, 2021)
March 19, 2021
PharmaShots Weekly Snapshot (April 27 -May 01, 2020)
May 4, 2020
PharmaShots Weekly Snapshot (February 24-28, 2020)
March 2, 2020
PharmaShots Weekly Snapshot (January 13-17, 2020)
January 20, 2020
Load more...
Back to Home
Modal title
×
Modal body text goes here.
